Vaccination

Extra safety scrutiny planned as virus vaccine worries grow

Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available—an added safety layer experts call vital.

Diseases, Conditions, Syndromes

NIH launches trial of antibody drugs against COVID-19

(HealthDay)—A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH).

Diseases, Conditions, Syndromes

Can an antibody 'cocktail' prevent COVID-19 infection?

In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients. The drug was recently administered ...

Diseases, Conditions, Syndromes

China to test whole city of 9m as Europe rolls out new virus rules

All nine million people in a major Chinese port city will be tested for COVID-19 following a tiny outbreak, health officials said Monday, as surging infection numbers in Europe force another round of containment efforts.

Diseases, Conditions, Syndromes

Trump-touted COVID-19 antibody treatments: what we know

Two US companies have applied for emergency approval for their lab-produced antibodies against COVID-19—and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.

Diseases, Conditions, Syndromes

Spanish court rejects lockdown as Europe faces virus surge

Madrid's top court struck down virus restrictions on millions in the Spanish capital on Thursday, while France put four more cities on its highest alert as European governments battled to control a sustained surge in virus ...

page 16 from 40